Sequential chemo-radiotherapy in non-small cell lung cancer.
Locally advanced non-small cell lung cancer (NSCLC) stage IIIA/IIIB represents approximately 30% of NSCLC and still has a poor prognosis. In this article we give a short review on several randomized phase III trials that showed a slight but significant survival benefit for sequential chemo-radiotherapy in the treatment of locally advanced NSCLC.
Kotas
M
M
Department of Radiation Oncology, University of Wuerzburg, Josef-Schneider-Strasse 11, D-97080, Würzburg, Germany.
Willner
J
J
Flentje
M
M
D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000532:radiotherapy*; D002986:Clinical Trials as Topic; D003131:Combined Modality Therapy; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000532:radiotherapy*; D009367:Neoplasm Staging; D011879:Radiotherapy Dosage